Ando K, Inoue T, Hikishima K, Komaki Y, Kawai K, Inoue R, Nishime C, Nishinaka E, Urano K, Okano H. Measurement of baseline locomotion and other behavioral traits in a common marmoset model of Parkinson's disease established by a single administration regimen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: providing reference data for efficacious precl. Behavioural pharmacology. 2020. 31. 1. 45-60
Differential effects of dopaminergic drugs on spontaneous motor activity in the common marmoset following pretreatment with a bilateral brain infusion of 6-hydroxydopamine. 2017. 28. 8. 670-680
稲次基希, 前田純, 安東潔, 樋口真人, 須原哲也, 岡野栄之, 成相直, 大野喜久郎. 6-OHDAラット胎仔中脳細胞移植のPETによる再生過程の評価. Functional neurosurgery : proceedings of the annual meeting of the Japan Society for Stereotactic and Functional Neurosurgery. 2006. 45. 1. 6-7
パーキンソン病モデル・マーモセットにおける in vivo イメージング検出による神経変性と行動的症候発現の相関
(第6回日本マーモセット研究会大会 2016)
Behavioral pharmacological effects of dopaminergic drugs in common marmosets pretreated with subcutaneous MPTP or intracerebral 6-OHDA
(The Society for Neuroscience 2014, Washington DC. 19 November 2014 2014)
Behavioral baseline of the MPTP-treated common marmoset in preclinical studies on Parkinson's disease.
(The Society for Neuroscience 2013, San Diego. 2013)
MPTP-induced Parkinson's disease model of the common marmoset as a guidepost and a stepping stone in developing neurodegenerative models in nonhuman primates.
(2013 KALAS International Symposium, Jeju island. 2013)